IAM
ELOX

Ion Asset Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Ion Asset Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,625
Closed -$2.24M – 26
2019
Q2 		$2.24M Buy
+5,625
New +$2.37M 0.57% 12

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ion Asset Management's ELOX Position: Q3 2019 in Review

Ion Asset Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2019, closing a stake of 5,625 shares — an estimated $2.24M sold.

Ion Asset Management first reported a position in ELOX in Q2 2019 and held it in 1 quarter. The position peaked at $2.24M in Q2 2019. 48 funds tracked by Wall St. Rank hold ELOX as of Q3 2019.

  • Ion Asset Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Ion Asset Management sold 5,625 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $2.24M.
  • Ion Asset Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Ion Asset Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $2.24M in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Ion Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.